NASH is traditionally diagnosed by liver biopsy, limited by subjective scoring and sampling error. This motivates identifying imaging-based biomarkers that might quantitatively characterize the pathophysiologic features of NASH. This prospective study established a streamlined imaging protocol for acquiring three candidate biomarkers ( fat fraction, liver stiffness, and T1 ) in a cohort of 66 patients with suspected NASH who underwent biopsy. The results indicate that a two-parameter model using fat fraction and liver stiffness has superior accuracy in diagnosing NASH, including ones that include the T1 relaxation time, which was found to have high collinearity with the fat fraction.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords